Scope Biosciences is developing a CRISPR-Cas based diagnostic platform for rapid point of care diagnostic solutions.
Location: Netherlands, Gelderland, Wageningen
Employees: 1-10
Total raised: $1.16M
Investors 1
| Date | Name | Website |
| 31.03.2022 | StartHub W... | starthubwa... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.11.2021 | - | $1.16M | - |
Mentions in press and media 7
| Date | Title | Description |
| 31.10.2023 | Scope Biosciences raises 500K investment from SHIFT and Oost NL | Scope Biosciences B.V., a pioneer in CRISPR-Cas based molecular diagnostics, announces a €500K investment round led by SHIFT Invest’s TTT fund and Oost NL. This funding propels the company’s groundbreaking work in developing and bringing ... |
| 25.10.2023 | Dutch-based Scope Biosciences bags €500K to develop, commercialise agricultural diagnostics with CRISPR-Cas-based tech | Read this article in: Dutch-based Scope Biosciences, a startup developing CRISPR-Cas based molecular diagnostics, announced that it has secured €500K in funding led by SHIFT Invest’s Thematic Technology Transfer fund and OostNL. The funding... |
| 26.08.2023 | Blooming Innovation: 15 Cutting-Edge Biotechnology Startups in The Netherlands | Table of Contents show 1 Introduction 2 New Amsterdam Pharma: Revolutionizing Cardio-Metabolic Therapies 3 The Protein Brewery: Crafting Sustainable, Animal-Free Proteins 4 Epify: Transforming Healthcare with Collaborative Innovation 5... |
| 16.11.2021 | Dutch biotech company Scope Biosciences raises €1M from GenDx to speed up development and marketing of its ScopeDx platform | Netherlands-based Scope Biosciences, a platform technology specialising in the development of molecular diagnostics using CRISPR-Cas, announced that it has raised €1M in a fresh round of funding. Niek Savelkoul, CEO of Scope Biosciences, sa... |
| 08.11.2021 | Biotech startup Scope Biosciences Attracts €1M Funding For CRISPR-diagnostic Platform | Scope Biosciences, a Wageningen University & Research spin-off and a StartLife portfolio company, announced to have raised an investment of €1M. The funding is provided by GenDx, a global leader in molecular diagnostic laboratory solu... |
| 12.03.2020 | StartLife Alumni Updates: March 2020 | Brief updates from StartLife Alumni and Community members StartLife alumni / community member EzCOL, a spin-off from the European Space Agency research program ‘MELiSSA’, has been working on the development of innovative highly effective ... |
| - | Scope Biosciences | “ScopeDx: Transforming molecular diagnostics with CRISPR-Cas.” |